Robert J. Gould
Interim President & CEO at Fulcrum Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Fulcrum Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Fulcrum Therapeutics Inc. June 26, 202594.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 2, 2026 | Fulcrum Therapeutics Inc. | Open-market sale | −15,000 | $10.72 | $160,800 |
| Jan 2, 2026 | Fulcrum Therapeutics Inc. | Open-market sale | −15,000 | $11.87 | $178,050 |
| Nov 19, 2025 | Fulcrum Therapeutics Inc. | Open-market sale | −15,000 | $11.03 | $165,450 |
| Jan 13, 2023 | Fulcrum Therapeutics Inc. | Open-market sale | −6,766 | $15.00 | $101,490 |
Questions about Robert J. Gould
What boards is Robert J. Gould on?
Robert J. Gould sits on the board of Fulcrum Therapeutics Inc.
What company is Robert J. Gould the CEO of?
Robert J. Gould is Interim President & CEO of Fulcrum Therapeutics Inc.
How long has Robert J. Gould served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.